Asia Pacific Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet's Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
The Asia Pacific endothelial dysfunction market is expected to grow from US$ 304.48 million in 2022 to US$ 405.51 million by 2028. It is estimated to grow at a CAGR of 4.9% from 2022 to 2028.
Rising Usage of Novel Biomarkers and Therapeutic Strategies Fuels Asia Pacific Endothelial Dysfunction Market
Examining endothelial function can improve risk stratification, improve early disease detection, and assess vascular response to therapeutic interventions. There are studies to understand the pathophysiological mechanisms underlying endothelial dysfunction and atherosclerosis progression in a better way and identify new biomarkers and therapeutic strategies to prevent endothelial dysfunction and atherosclerosis to reduce the risk of developing coronary artery disease (CAD) and related complications. Using liquid biopsies and new molecular biology techniques has enabled the identification of a growing list of molecular and cellular markers of endothelial dysfunction that have provided insight into the molecular basis of atherosclerosis as well as potential biomarkers and therapeutic targets for the prevention and treatment of atherosclerosis and CAD.
Research on biomarkers and their clinical application has increased exponentially over the last few decades. Invaluable insight into the pathophysiology of atherosclerosis and the development of novel therapies have been provided by systemic biomarkers. Endothelial dysfunction and inflammation play a central role in the development and progression of CAD. Inflammatory mediators are secreted by inflammatory and vascular cells in atherosclerotic plaque or by organs such as the liver or adipose tissue.
Asia Pacific Endothelial Dysfunction Market Overview
The endothelial dysfunction market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market in the region is attributed to the increasing cases of endothelial dysfunction with the rising incidence of CVD, hypertension, diabetes, and chronic diseases, coupled with the growing aging population. In addition, the market is driven by increasing investments in diagnostics techniques by the respective country governments, resulting in advancements in diagnostics methods.
Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Endothelial Dysfunction Market Segmentation
The Asia Pacific endothelial dysfunction market is segmented into cause, test type, end user, and country.
Based on cause, the Asia Pacific endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, Behcet's disease, and others. The hypertension segment registered the largest Asia Pacific endothelial dysfunction market share in 2022.
Based on test type, the Asia Pacific endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Asia Pacific endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.
Based on end user, the Asia Pacific endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Asia Pacific endothelial dysfunction market share in 2022.
Based on country, the Asia Pacific endothelial dysfunction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endothelial dysfunction market in 2022.
ZOLL Medical Corp, Sphingo Tec GmbH, Perimed AB, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.
Rising Usage of Novel Biomarkers and Therapeutic Strategies Fuels Asia Pacific Endothelial Dysfunction Market
Examining endothelial function can improve risk stratification, improve early disease detection, and assess vascular response to therapeutic interventions. There are studies to understand the pathophysiological mechanisms underlying endothelial dysfunction and atherosclerosis progression in a better way and identify new biomarkers and therapeutic strategies to prevent endothelial dysfunction and atherosclerosis to reduce the risk of developing coronary artery disease (CAD) and related complications. Using liquid biopsies and new molecular biology techniques has enabled the identification of a growing list of molecular and cellular markers of endothelial dysfunction that have provided insight into the molecular basis of atherosclerosis as well as potential biomarkers and therapeutic targets for the prevention and treatment of atherosclerosis and CAD.
Research on biomarkers and their clinical application has increased exponentially over the last few decades. Invaluable insight into the pathophysiology of atherosclerosis and the development of novel therapies have been provided by systemic biomarkers. Endothelial dysfunction and inflammation play a central role in the development and progression of CAD. Inflammatory mediators are secreted by inflammatory and vascular cells in atherosclerotic plaque or by organs such as the liver or adipose tissue.
Asia Pacific Endothelial Dysfunction Market Overview
The endothelial dysfunction market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market in the region is attributed to the increasing cases of endothelial dysfunction with the rising incidence of CVD, hypertension, diabetes, and chronic diseases, coupled with the growing aging population. In addition, the market is driven by increasing investments in diagnostics techniques by the respective country governments, resulting in advancements in diagnostics methods.
Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Endothelial Dysfunction Market Segmentation
The Asia Pacific endothelial dysfunction market is segmented into cause, test type, end user, and country.
Based on cause, the Asia Pacific endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, Behcet's disease, and others. The hypertension segment registered the largest Asia Pacific endothelial dysfunction market share in 2022.
Based on test type, the Asia Pacific endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Asia Pacific endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.
Based on end user, the Asia Pacific endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Asia Pacific endothelial dysfunction market share in 2022.
Based on country, the Asia Pacific endothelial dysfunction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endothelial dysfunction market in 2022.
ZOLL Medical Corp, Sphingo Tec GmbH, Perimed AB, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Endothelial Dysfunction Market - by Cause
1.3.2 Asia Pacific Endothelial Dysfunction Market - by Test Type
1.3.3 Asia Pacific Endothelial Dysfunction Market - by End User
1.3.4 Asia Pacific Endothelial Dysfunction Market - by Country
2. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET - MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Expert Opinion
5. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Incidences of Cardiovascular Diseases
5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
5.2 Market Restraints
5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
5.3 Market Opportunities
5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
5.4 Future Trends
5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
5.5 Impact Analysis
6. ENDOTHELIAL DYSFUNCTION MARKET - ASIA PACIFIC ANALYSIS
6.1 Asia Pacific Endothelial Dysfunction Market Revenue Forecast and Analysis
7. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET ANALYSIS - BY CAUSE
7.1 Overview
7.2 Asia Pacific Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
7.3 Hypertension
7.3.1 Overview
7.3.2 Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.4 Diabetes
7.4.1 Overview
7.4.2 Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.5 Hypercholestrolaemia
7.5.1 Overview
7.5.2 Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.6 Behcet's Disease
7.6.1 Overview
7.6.2 Behcet's Disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.7 Obesity
7.7.1 Overview
7.7.2 Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET ANALYSIS - BY TEST TYPE
8.1 Overview
8.2 Asia Pacific Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
8.3 Invasive Tests
8.3.1 Overview
8.3.2 Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Invasive Tests
8.4.1 Overview
8.4.2 Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.3 Flow Mediated Dilatory
8.4.3.1 Overview
8.4.3.2 Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.4 Venous Occlusion Plethysmography
8.4.4.1 Overview
8.4.4.2 Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.5 Peripheral Arterial Tonometry (PAT)
8.4.5.1 Overview
8.4.5.2 Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.6 Circulating Markers
8.4.6.1 Overview
8.4.6.2 Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.7 Others
8.4.7.1 Overview
8.4.7.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET ANALYSIS - BY END USER
9.1 Overview
9.2 Asia Pacific Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostics Centers
9.4.1 Overview
9.4.2 Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinics
9.5.1 Overview
9.5.2 Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET - REVENUE AND FORECAST TO 2028 - COUNTRY ANALYSIS
10.1 Asia Pacific: Endothelial Dysfunction Market
10.1.1 Overview
10.1.1.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
11. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Endothelial Dysfunction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 ZOLL Medical Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sphingo Tec GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Perimed AB
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medizinische Messtechnik GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Endothelial Dysfunction Market - by Cause
1.3.2 Asia Pacific Endothelial Dysfunction Market - by Test Type
1.3.3 Asia Pacific Endothelial Dysfunction Market - by End User
1.3.4 Asia Pacific Endothelial Dysfunction Market - by Country
2. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET - MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Expert Opinion
5. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Incidences of Cardiovascular Diseases
5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
5.2 Market Restraints
5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
5.3 Market Opportunities
5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
5.4 Future Trends
5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
5.5 Impact Analysis
6. ENDOTHELIAL DYSFUNCTION MARKET - ASIA PACIFIC ANALYSIS
6.1 Asia Pacific Endothelial Dysfunction Market Revenue Forecast and Analysis
7. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET ANALYSIS - BY CAUSE
7.1 Overview
7.2 Asia Pacific Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
7.3 Hypertension
7.3.1 Overview
7.3.2 Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.4 Diabetes
7.4.1 Overview
7.4.2 Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.5 Hypercholestrolaemia
7.5.1 Overview
7.5.2 Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.6 Behcet's Disease
7.6.1 Overview
7.6.2 Behcet's Disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.7 Obesity
7.7.1 Overview
7.7.2 Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET ANALYSIS - BY TEST TYPE
8.1 Overview
8.2 Asia Pacific Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
8.3 Invasive Tests
8.3.1 Overview
8.3.2 Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Invasive Tests
8.4.1 Overview
8.4.2 Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.3 Flow Mediated Dilatory
8.4.3.1 Overview
8.4.3.2 Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.4 Venous Occlusion Plethysmography
8.4.4.1 Overview
8.4.4.2 Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.5 Peripheral Arterial Tonometry (PAT)
8.4.5.1 Overview
8.4.5.2 Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.6 Circulating Markers
8.4.6.1 Overview
8.4.6.2 Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.7 Others
8.4.7.1 Overview
8.4.7.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET ANALYSIS - BY END USER
9.1 Overview
9.2 Asia Pacific Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostics Centers
9.4.1 Overview
9.4.2 Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinics
9.5.1 Overview
9.5.2 Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET - REVENUE AND FORECAST TO 2028 - COUNTRY ANALYSIS
10.1 Asia Pacific: Endothelial Dysfunction Market
10.1.1 Overview
10.1.1.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
11. ASIA PACIFIC ENDOTHELIAL DYSFUNCTION MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Endothelial Dysfunction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 ZOLL Medical Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sphingo Tec GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Perimed AB
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medizinische Messtechnik GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Techniques Used in to Assess Endothelial Function
Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
Table 3. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 4. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 6. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 12. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 14. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 20. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 22. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
Table 29. Glossary of Terms, Endothelial dysfunction market
Table 1. Techniques Used in to Assess Endothelial Function
Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
Table 3. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 4. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 6. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 12. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 14. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 20. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 22. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
Table 29. Glossary of Terms, Endothelial dysfunction market
LIST OF FIGURES
Figure 1. Asia Pacific Endothelial Dysfunction Market Segmentation
Figure 2. Asia Pacific Endothelial Dysfunction Market, by Country
Figure 3. Asia Pacific Endothelial Dysfunction Market Overview
Figure 4. Hypertension Account for Largest Share of Cause Segment in Asia Pacific Endothelial Dysfunction Market
Figure 5. China Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Asia Pacific Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Asia Pacific Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
Figure 11. Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Behcet's disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Asia Pacific Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
Figure 18. Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Asia Pacific Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
Figure 26. Hospitals and Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 32. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Growth Strategies in the Endothelial Dysfunction Market
Figure 1. Asia Pacific Endothelial Dysfunction Market Segmentation
Figure 2. Asia Pacific Endothelial Dysfunction Market, by Country
Figure 3. Asia Pacific Endothelial Dysfunction Market Overview
Figure 4. Hypertension Account for Largest Share of Cause Segment in Asia Pacific Endothelial Dysfunction Market
Figure 5. China Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Asia Pacific Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Asia Pacific Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
Figure 11. Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Behcet's disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Asia Pacific Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
Figure 18. Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Asia Pacific Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
Figure 26. Hospitals and Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 32. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Growth Strategies in the Endothelial Dysfunction Market
